Chapter 4: Biological Basis for Understanding Psychopharmacology

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

Biological Basis for Understanding Psychopharmacology details the anatomy and physiology of the brain, including the functions of the cerebrum’s lobes (frontal, parietal, temporal, occipital), the limbic system (amygdala, hippocampus) which regulates emotion and memory, and the brainstem’s role in vital functions. The text explains the critical process of neurotransmission, describing how neurons communicate via chemical messengers such as monoamines (dopamine, norepinephrine, serotonin), amino acids (GABA, glutamate), and cholinergics (acetylcholine). Key concepts in neuroimaging are reviewed, highlighting the utility of CT, MRI, fMRI, PET, and SPECT scans in visualizing structural and functional brain abnormalities associated with conditions like schizophrenia and depression. The chapter offers an in-depth analysis of major psychotropic drug classes, including their mechanisms of action (pharmacodynamics) and how the body processes them (pharmacokinetics), with specific attention to cytochrome P450 (CYP450) enzyme interactions. It covers antidepressants, differentiating between Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs), and Monoamine Oxidase Inhibitors (MAOIs), while emphasizing safety concerns like serotonin syndrome and hypertensive crises. The discussion extends to antianxiety agents (benzodiazepines and buspirone), mood stabilizers (lithium and anticonvulsants like valproate and lamotrigine), and the distinction between First-Generation Antipsychotics (FGAs) and Second-Generation Antipsychotics (SGAs). Significant side effects are examined, such as Extrapyramidal Symptoms (EPS), Neuroleptic Malignant Syndrome (NMS), metabolic syndrome, and agranulocytosis associated with clozapine. Finally, the chapter addresses the emerging fields of psychoneuroimmunology and pharmacogenetics, stressing the importance of cultural considerations in medication adherence and efficacy.